Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Fachveröffentlichungen

USA. Increasing Utilization of Gabapentin in the US and Associated Harms

USA. Increasing Utilization of Gabapentin in the US and Associated Harms

Gabapentin is widely prescribed for many conditions; most use is off-label, which has led to increasing concerns for the potential harms of therapeutic and nontherapeutic use (NTU). Researchers collected 2013–2023 pharmacy data on US prescribing trends and poison control (PC) reports involving exposure to gabapentin. They compared gabapentin with three other medications: pregabalin, diazepam, and oxycodone. (Alcohol, Other Drugs, and Health: Current Evidence , USA, Oktober 2026)

https://www.bu.edu/aodhealth/2026/10/28/increasing-utilization-of-gabapentin-in-the-us-and-associated-harms/